Subcutaneous Alemtuzumab Is a Safe and Effective Treatment for Global or Single-Lineage Immune-Mediated Marrow Failures: a Survey from the EBMT-WPSAA
暂无分享，去创建一个
J. Passweg | A. Tichelli | A. Risitano | A. Bacigalupo | H. Schrezenmeier | G. Socié | Vikas Gupta | B. Rotoli | Ludovica Marando | C. Selleri | L. Vecchio | J. Halter | S. Maury | A. Kulagin | J. Marsh | G. Scalia | A. Iori | B. Serio | E. Seneca